Cheree H Johnson

Insider

First SEC filing: Jan. 13, 2023 · Latest: Jan. 13, 2023

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Jan. 13, 2023	XRAY	A	291	—	—	83,059 Direct	+0.35%	Acquired	(price as of 2026-08-20)
Nov. 16, 2022	XRAY	F	7,893	$30.60	$241,526	82,584 Direct	-8.72%	Disposed	-64.2% (price as of 2026-08-20)
Nov. 16, 2022	XRAY	A	65,359	—	—	90,477 Direct	+260.21%	Acquired	(price as of 2026-08-20)
Oct. 14, 2022	XRAY	A	110	—	—	25,118 Direct	+0.44%	Acquired	(price as of 2026-08-20)
July 8, 2022	XRAY	A	85	—	—	25,007 Direct	+0.34%	Acquired	(price as of 2026-08-20)
April 8, 2022	XRAY	A	63	—	—	24,923 Direct	+0.25%	Acquired	(price as of 2026-08-20)
March 4, 2022	XRAY	A	21,200	—	—	21,200 Direct	—	Acquired	(price as of 2026-08-20)
March 4, 2022	XRAY	A	18,762	—	—	24,860 Direct	+307.67%	Acquired	(price as of 2026-08-20)
March 4, 2022	XRAY	A	6,098	—	—	6,098 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 4, 2022	XRAY	Stock Option (Right to Buy)	Common Stock (21,200)	$53.30	March 4, 2032	21,200	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).